Literature DB >> 29433059

Resveratrol liposomes and lipid nanocarriers: Comparison of characteristics and inducing browning of white adipocytes.

Yujiao Zu1, Haley Overby2, Guofeng Ren3, Zhaoyang Fan3, Ling Zhao4, Shu Wang5.   

Abstract

Trans-resveratrol (R) has a potential to increase energy expenditure via inducing browning in white adipose tissue. However, its low levels of aqueous solubility, stability, and poor bioavailability limit its application. We have successfully synthesized biocompatible, and biodegradable R encapsulated lipid nanocarriers (R-nano), and R encapsulated liposomes (R-lipo). The mean particle size of R-nano and R-lipo were 140 nm and 110 nm, respectively, and their polydispersity index values were less than 0.2. Nanoencapsulation significantly increased aqueous solubility and enhanced chemical stability of R, especially at 37 °C. R-lipo had higher physical and chemical stability than R-nano while R-nano had more prolonged release than R-lipo. Both R-nano and R-lipo increased cellular R content in 3T3-L1 cells. Both R-nano and R-lipo dose-dependently induced uncoupling protein 1 (UCP1) mRNA expression and decreased white specific marker insulin growth factor binding protein 3 expression under isoproterenol (ISO)-stimulated conditions. At the low dose (5 μM), nanoencapsulated compared to native R enhanced UCP1 and beige marker CD137 expression under ISO-stimulated conditions. Compared to R-nano, R-lipo had better biological activity, possibly due to its higher physical and chemical stability at the room and body temperature. Taken together, our study demonstrates that nanoencapsulation increased R's aqueous solubility and stability, which led to enhanced browning of white adipocytes. Even though both R-lipo and R-nano increased R's browning activities, their differential characteristics need to be considered in obesity treatment.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Beige cell; Brown adipocyte; Liposome; Nanocarrier; Nanomedicine; Obesity; Trans-resveratrol; White adipocyte

Mesh:

Substances:

Year:  2017        PMID: 29433059      PMCID: PMC5915363          DOI: 10.1016/j.colsurfb.2017.12.044

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  32 in total

1.  Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases.

Authors:  Sung-Jun Park; Faiyaz Ahmad; Andrew Philp; Keith Baar; Tishan Williams; Haibin Luo; Hengming Ke; Holger Rehmann; Ronald Taussig; Alexandra L Brown; Myung K Kim; Michael A Beaven; Alex B Burgin; Vincent Manganiello; Jay H Chung
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

2.  Monoterpene phenolic compound thymol promotes browning of 3T3-L1 adipocytes.

Authors:  Jae Heon Choi; Sang Woo Kim; Rina Yu; Jong Won Yun
Journal:  Eur J Nutr       Date:  2016-07-18       Impact factor: 5.614

3.  Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages.

Authors:  James A Timmons; Kristian Wennmalm; Ola Larsson; Tomas B Walden; Timo Lassmann; Natasa Petrovic; D Lee Hamilton; Ruth E Gimeno; Claes Wahlestedt; Keith Baar; Jan Nedergaard; Barbara Cannon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

4.  Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size.

Authors:  Ganeshchandra Sonavane; Keishiro Tomoda; Kimiko Makino
Journal:  Colloids Surf B Biointerfaces       Date:  2008-07-15       Impact factor: 5.268

5.  Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles.

Authors:  Jia Zhang; Shufang Nie; Raul Martinez-Zaguilan; Souad R Sennoune; Shu Wang
Journal:  J Nutr Biochem       Date:  2015-12-02       Impact factor: 6.048

6.  Resveratrol increases brown adipose tissue thermogenesis markers by increasing SIRT1 and energy expenditure and decreasing fat accumulation in adipose tissue of mice fed a standard diet.

Authors:  João Marcus Oliveira Andrade; Alessandra Caroline Montes Frade; Juliana Bohnen Guimarães; Kátia Michelle Freitas; Miriam Teresa Paz Lopes; André Luiz Sena Guimarães; Alfredo Maurício Batista de Paula; Cândido Celso Coimbra; Sérgio Henrique Sousa Santos
Journal:  Eur J Nutr       Date:  2014-01-28       Impact factor: 5.614

7.  Trans-resveratrol self-nano-emulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies.

Authors:  Gurinder Singh; Roopa S Pai
Journal:  Drug Deliv       Date:  2014-02-11       Impact factor: 6.419

8.  Quercetin-nanostructured lipid carriers: characteristics and anti-breast cancer activities in vitro.

Authors:  Ming Sun; Shufang Nie; Xuan Pan; Ruiwen Zhang; Zhaoyang Fan; Shu Wang
Journal:  Colloids Surf B Biointerfaces       Date:  2013-09-01       Impact factor: 5.268

9.  Using liposomes as carriers for polyphenolic compounds: the case of trans-resveratrol.

Authors:  Claudia Bonechi; Silvia Martini; Laura Ciani; Stefania Lamponi; Herbert Rebmann; Claudio Rossi; Sandra Ristori
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

10.  Acetate alters expression of genes involved in beige adipogenesis in 3T3-L1 cells and obese KK-Ay mice.

Authors:  Satoko Hanatani; Hiroyuki Motoshima; Yuki Takaki; Shuji Kawasaki; Motoyuki Igata; Takeshi Matsumura; Tatsuya Kondo; Takafumi Senokuchi; Norio Ishii; Junji Kawashima; Daisuke Kukidome; Seiya Shimoda; Takeshi Nishikawa; Eiichi Araki
Journal:  J Clin Biochem Nutr       Date:  2016-09-08       Impact factor: 3.114

View more
  9 in total

1.  Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cells.

Authors:  Haider Rasheed Alrafas; Philip B Busbee; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Leukoc Biol       Date:  2019-03-21       Impact factor: 4.962

Review 2.  Strategies for Browning Agent Delivery.

Authors:  Wentao Zhang; Tao Sheng; Zhen Gu; Yuqi Zhang
Journal:  Pharm Res       Date:  2021-08-16       Impact factor: 4.200

Review 3.  Polymeric Carriers for Controlled Drug Delivery in Obesity Treatment.

Authors:  Di Huang; Meng Deng; Shihuan Kuang
Journal:  Trends Endocrinol Metab       Date:  2019-10-25       Impact factor: 12.015

4.  Browning white adipose tissue using adipose stromal cell-targeted resveratrol-loaded nanoparticles for combating obesity.

Authors:  Yujiao Zu; Ling Zhao; Lei Hao; Yehia Mechref; Masoud Zabet-Moghaddam; Peter A Keyel; Mehrnaz Abbasi; Dayong Wu; John A Dawson; Ruiwen Zhang; Shufang Nie; Naima Moustaid-Moussa; Mikhail G Kolonin; Alexes C Daquinag; Luis Brandi; Irfan Warraich; Susan K San Francisco; Xiaocun Sun; Zhaoyang Fan; Shu Wang
Journal:  J Control Release       Date:  2021-03-23       Impact factor: 11.467

Review 5.  Brown and Brite: The Fat Soldiers in the Anti-obesity Fight.

Authors:  Shireesh Srivastava; Richard L Veech
Journal:  Front Physiol       Date:  2019-01-30       Impact factor: 4.566

Review 6.  Nanotechnology advances towards development of targeted-treatment for obesity.

Authors:  Nicole Remaliah Samantha Sibuyi; Koena Leah Moabelo; Mervin Meyer; Martin Opiyo Onani; Admire Dube; Abram Madimabe Madiehe
Journal:  J Nanobiotechnology       Date:  2019-12-16       Impact factor: 10.435

7.  Nano-Resveratrol: A Promising Candidate for the Treatment of Renal Toxicity Induced by Doxorubicin in Rats Through Modulation of Beclin-1 and mTOR.

Authors:  Ahlam M Alhusaini; Laila M Fadda; Abeer M Alanazi; Wedad S Sarawi; Hatun A Alomar; Hanaa M Ali; Iman H Hasan; Rehab Ahmed Ali
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

Review 8.  Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities.

Authors:  Jing Li; Hongli Duan; Yan Liu; Lu Wang; Xing Zhou
Journal:  Pharmaceutics       Date:  2022-07-11       Impact factor: 6.525

9.  Enhanced biological activity of liposomal methylated resveratrol analog 3'-hydroxy-3,4,5,4'-tetramethoxystilbene (DMU-214) in 3D patient-derived ovarian cancer model.

Authors:  Andrzej Nowicki; Dariusz Wawrzyniak; Mikołaj Czajkowski; Małgorzata Józkowiak; Michał Pawlak; Marcin Wierzchowski; Katarzyna Rolle; Paulina Skupin-Mrugalska; Hanna Piotrowska-Kempisty
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.